Sort
11,323 grants matching “glioblastoma”
Genomics & Bioinformatics
$209,365Cameron Brennan · Dana-Farber Cancer Inst · P01 · FY2011 · CA
Methods for controlling small RNA stability
$209,344Ian John Macrae · Scripps Research Institute, The · R21 · FY2017 · CA
Preclinical Validation of Polyvalent siRNA Gold Nanoparticle Conjugates as anti-G
$209,018Alexander H. Stegh · Northwestern University At Chicago · U54 · FY2012 · CA
Leveraging MR-Guided Focused Ultrasound to Potentiate Immunotherapy for GBM
$208,881Timothy N Bullock · University Of Virginia · R21 · FY2020 · CA
Collateral Deletions Expose Targetable Metabolic Vulnerabilities in the PTEN locus
$208,800Florian Muller · University Of Tx Md Anderson Can Ctr · R21 · FY2018 · CA
Modulation of Glioma Growth and Invasion by HCMV Glycoprotein B
$208,766Liliana Soroceanu · California Pacific Med Ctr Res Institute · R21 · FY2010 · NS
Microvesicles as potential genetic biomarkers of brain tumors
$208,541Xandra Owens Breakefield · Massachusetts General Hospital · P01 · FY2015 · CA
Targeted nanotechnology for the pancreatic tumor immune microenvironment
$208,538Martin G Pomper · Ut Southwestern Medical Center · P41 · FY2024 · EB
The role of class IIa Hdac in regulating cell fate choice in early cortical development.
$208,500Diane C Darland · University Of North Dakota · P20 · FY2019 · GM
Novel fluorinated amino ester prodrugs for PET imaging of gliomas
$208,271Jonathan Edward McConathy · University Of Alabama At Birmingham · R21 · FY2019 · CA
Engineering a multispecific receptor antagonist to inhibit cancer metastasis
$208,258Jennifer R Cochran · Stanford University · R21 · FY2014 · CA
Tasquinimod as an adjunct to immunotherapies administered peri-operatively
$208,097Jana Portnow · Beckman Research Institute/City Of Hope · U19 · FY2021 · CA
MRI Assessment of Anti-angiogenesis in Mouse Gliomas
$207,900Martin M Pike · Oregon Health & Science University · R21 · FY2009 · CA
Engineering class I MHC molecules to drive enhanced anti-cancer responses
$207,898David M Kranz · University Of Illinois At Urbana-Champaign · R21 · FY2022 · CA
Toward Changing Glioblastoma Outcomes: Targeted drug delivery of an inhibitory biopolymer in conjunction with systemic chemotherapy
$207,841Drazen Raucher · University Of Mississippi Med Ctr · R21 · FY2019 · CA
Project 2 Single EV protein characterization and evaluation in clinical trials
$207,822Ralph Weissleder · Massachusetts General Hospital · P01 · FY2019 · CA
Usurping TIGIT and CD73 activities with responsive, genetically-engineered NK cells as immunotherapy for glioblastoma
$207,796Sandro Matosevic · Purdue University · R21 · FY2022 · CA
Microvesicles as potential genetic biomarkers of brain tumors
$207,781Xandra Owens Breakefield · Massachusetts General Hospital · P01 · FY2016 · CA
Molecular Analysis and Role of RGS6 as a Novel Growth Suppressor
$207,560Rory A. Fisher · University Of Iowa · R01 · FY2009 · GM
Enhancing Glioma-Specific Immunity
$207,495Aaron J Johnson · Mayo Clinic Rochester · R21 · FY2015 · CA
In vivo detection of 2-hydroxyglutarate in gliomas by spectroscopic MRI
$207,495Changho Choi · Ut Southwestern Medical Center · R21 · FY2012 · CA
Analysis of alphaVbeta8 Integrin In Gliomagenesis
$207,468Joseph H McCarty · University Of Tx Md Anderson Can Ctr · R01 · FY2009 · NS
Enhanced intra-arterial drug delivery to the brain after blood brain barrier opening: comparison between osmotic and MRI-guided focused ultrasound opening techniques
$207,399Monica Smith Pearl · Children'S Research Institute · R21 · FY2022 · NS
A Forward Genetic Approach To Studying Glioma Formation and Therapy Resistance
$207,388Lara S Collier · University Of Wisconsin-Madison · R21 · FY2010 · NS
GADOLINIUM TEXAPHYRIN AS RADIATION SENSITIZER
$207,266University Of California Los Angeles · M01 · FY2001 · RR